Dr. Philip Forni is a Roselle, Illinois based male podiatrist who is specialized in Podiatry. Active license number of Dr. Philip Forni for Podiatry is 16-2960 in Illinois. Dr. Philip Forni is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Dr. Philip Forni speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Male
Practice Address:
825 N Roselle Rd, Roselle, Illinois, 60172-4212
Phone:
630-582-1100
Fax:
630-582-1165
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1699897264
NPI Enumeration Date:
04 Apr, 2007
NPI Last Update On:
13 Mar, 2017
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Philip Forni are as mentioned below.
License Number
Specialization
State
Status
16-2960
Podiatry
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 72116, Roselle, Illinois
Zip:
60172-0116
Phone Number:
630-582-1100
Fax Number:
630-582-1165
Patients can reach Dr. Philip Forni at 825 N Roselle Rd, Roselle, Illinois or can call to book an appointment on 630-582-1100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.